Format

Send to

Choose Destination
Expert Opin Investig Drugs. 2006 Feb;15(2):163-9.

Anecortave acetate.

Author information

1
Cole Eye Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk i3, Cleveland, OH 44195, USA.

Erratum in

  • Expert Opin Investig Drugs. 2006 May;15(5):573.

Abstract

This manuscript reviews the pharmacotherapeutics of the novel, angiostatic cortisene, anecortave acetate suspension, for the treatment of age-related macular degeneration. The chemistry, pharmacokinetics and pharmacodynamics of anecortave acetate are discussed, and the results of the multi-centre, randomised, controlled clinical trials for the treatment of subfoveal choroidal neovascularisation in age-related macular degeneration summarised. It also discusses ongoing clinical trials involving anecortave acetate for dry and wet age-related macular degeneration.

PMID:
16433595
DOI:
10.1517/13543784.15.2.163
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center